✨ Free AI Report
Integra LifeSciences Holdings Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Integra LifeSciences Holdings Corporation
Company Research

Integra LifeSciences Holdings Corporation: Business Overview, Financials & Competitive Analysis

Integra LifeSciences (NASDAQ: IART) develops and manufactures medical technologies for neurosurgery, wound care, and surgical reconstruction, including regenerative tissue products and surgical instruments. The compan...

Analyst-debate audio for Integra LifeSciences Holdings Corporation

AskCyborg analysts argue the bull and bear cases for Integra LifeSciences Holdings Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
3/ 10Challenged

Cyborg Score thesis

Turnaround candidate with operational progress offset by elevated debt, legacy write-downs, and modest organic growth...

Read the full analyst-debate transcript →
Industry Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery)
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Integra LifeSciences Holdings Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Integra LifeSciences Holdings Corporation Overview

Pro stress-test →

Integra LifeSciences (NASDAQ: IART) develops and manufactures medical technologies for neurosurgery, wound care, and surgical reconstruction, including regenerative tissue products and surgical instruments. The company operates in the specialized medical device sector, delivering life-saving technologies to healthcare professionals worldwide.

Strategic Profile

Pro stress-test →

Integra is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The company expects flat to low single-digit growth in its Codman Specialty Surgical segment and low to mid-single-digit growth in its Tissue Tech segment for 2026.

Competitive Landscape

Pro stress-test →

Integra LifeSciences is a global medical technology company specializing in products and innovations for neurosurgery, regenerative medicine and reconstructive procedures. The company competes with larger diversified medical device manufacturers and specialized orthopedic/neurosurgery device makers in fragmented markets.

Industry Context

Integra LifeSciences Holdings Corporation operates in Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery).

Key facts

Founded: 1989 · Headquarters: Princeton, New Jersey, United States · Revenue: $1.64B (TTM) · Market cap: $0.9B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Integra LifeSciences Holdings Corporation.

  • Q4 results exceeded expectations with adjusted EPS of $0.83 topping consensus of $0.79; management highlighted operational progress and a simplified operating model expected to deliver $25–$30M of savings in 2026.
  • Company continues to see strong demand across both business segments, with strong momentum expected on Integra Skin to drive full year growth expectations.
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • Feb 2026Q4 2025 earnings: adjusted EPS $0.83 beat consensus; 2026 guidance $2.30-$2.40 EPS, flat to mid-single-digit revenue growth expected
  • Feb 2026Announced simplified operating model targeting $25-$30M cost savings in 2026
  • +1 moreTrack every material event for Integra LifeSciences Holdings Corporation as it happens. Explore monitoring →
Get alerted when Integra LifeSciences Holdings Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Spinal Fusion & Orthopedic DevicesMajor competitor in neurosurgery and spine markets→Surgical Instruments & Regenerative MedicineCompetitor in orthopedic reconstruction and tissue regeneration→Neurosurgical DevicesCompetitor in surgical navigation and neurosurgical instruments→

Compare Integra LifeSciences Holdings Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Integra LifeSciences Holdings Corporation operates in Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery). See how the rest of the sector scores on the Cyborg framework.

Browse Medical Devices & Supplies - Specialty (Neurosurgery, Wound Care, Reconstructive Surgery) research →
NEW · MCP server

Ask your AI assistant about Integra LifeSciences Holdings Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Integra LifeSciences Holdings Corporation and its top competitor on Cyborg Score”
“What did Integra LifeSciences Holdings Corporation do this quarter?”
“Is Integra LifeSciences Holdings Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Integra LifeSciences Holdings Corporation do?+
Integra LifeSciences (NASDAQ: IART) develops and manufactures medical technologies for neurosurgery, wound care, and surgical reconstruction, including regenerative tissue products and surgical instruments. The compan...
What is Integra LifeSciences Holdings Corporation's Cyborg Score?+
Integra LifeSciences Holdings Corporation has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Integra LifeSciences Holdings Corporation's main competitors?+
Named competitors include Spinal Fusion & Orthopedic Devices, Surgical Instruments & Regenerative Medicine, Neurosurgical Devices. The full competitive landscape is in the AskCyborg report.
How can I get the full Integra LifeSciences Holdings Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Integra LifeSciences Holdings Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Integra LifeSciences Holdings Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.